[Treatment of osteoporosis].
Reza-Albarrán
A A
AA
Instituto Nacional de la Nutrición, México, D.F.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000008:administration & dosage / Q000627:therapeutic use; D000863:Antacids / Q000008:administration & dosage; D002119:Calcium Carbonate / Q000008:administration & dosage; D002136:Calcium, Dietary / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005459:Fluorides / Q000008:administration & dosage; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010024:Osteoporosis / Q000517:prevention & control / Q000628:therapy*; D010710:Phosphates / Q000008:administration & dosage; D005082:Physical Exertion; D045167:Progesterone Congeners / Q000627:therapeutic use; D013997:Time Factors; D014807:Vitamin D / Q000627:therapeutic use
D000863:Antacids; D002136:Calcium, Dietary; D004967:Estrogens; D010710:Phosphates; D045167:Progesterone Congeners; D014807:Vitamin D; C012980:fluorophosphate; D002119:Calcium Carbonate; D008525:Medroxyprogesterone; D005459:Fluorides; D019386:Alendronate
Tratamiento de osteoporosis.